Australia markets closed

Palla Pharma Limited (PAL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.29500.0000 (0.00%)
At close: 03:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 47.76M
Enterprise value 62.42M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.47
Price/book (mrq)2.38
Enterprise value/revenue 3.74
Enterprise value/EBITDA -1.15

Trading information

Stock price history

Beta (5Y monthly) 1.17
52-week change 3-20.27%
S&P500 52-week change 3-11.33%
52-week high 30.4050
52-week low 30.2000
50-day moving average 30.2950
200-day moving average 30.3089

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5161.91M
Implied shares outstanding 6N/A
Float 8114.66M
% held by insiders 111.61%
% held by institutions 128.62%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)30 June 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-209.25%

Management effectiveness

Return on assets (ttm)-32.19%
Return on equity (ttm)-143.87%

Income statement

Revenue (ttm)16.74M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)-42.70%
Gross profit (ttm)-1.15M
EBITDA -32.54M
Net income avi to common (ttm)-58.85M
Diluted EPS (ttm)-0.4300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)897.31k
Total cash per share (mrq)0.01
Total debt (mrq)15.55M
Total debt/equity (mrq)77.50
Current ratio (mrq)1.09
Book value per share (mrq)0.12

Cash flow statement

Operating cash flow (ttm)-22.69M
Levered free cash flow (ttm)-10.07M